设为首页 加入收藏

TOP

最新六年试验数据证明 FOSRENOL 是末期肾病患者的治疗选择(四)
2018-02-05 02:21:51 来源: 作者: 【 】 浏览:1967次 评论:0
       1998; 31:607-617.
    (16) Market Research, Insight International, Dec 01/Jan 02
         Hyperphosphataemia Exploratory Research J1524
    (17) http://www.emedicine.com/emerg/topic266.htm .  “Hyperphosphatemia,”
         by Leigh A Patterson, MD, Staff Physician, Department of Emergency
         Medicine, Charity Hospital, Louisiana State University, December 11,
         2001.
    (18) Molowa DT.  First annual nephrology survey. JP Morgan Securities
         Inc., Equity Research, February 13, 2002. 
    (19) FOSRENOL(R) U.S. PI.
    (20) http://www.kidney.org/professionals/kdoqi/guidelines_bone/guide3/htm .
         K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease
         in Chronic Kidney Disease. National Kidney Foundation. Accessed June
         17, 2004.
    (21) http://www.kidney.org/professionals/kdoqi/guidelines_bone/guide5.htm
         K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease
         in Chronic Kidney Disease. National Kidney Foundation. Accessed June
         17, 2004. 
Tags: 责任编辑:admin
首页 上一页 1 2 3 4 下一页 尾页 4/4/4
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇默沙东新型HIV药物Doravirine在美.. 下一篇三个月给药一次的精神分裂症药Inv..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位